These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 14534739

  • 1. P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences.
    Dahse R, Gärtner D, Werner W, Schubert J, Junker K.
    Oncol Rep; 2003; 10(6):2033-7. PubMed ID: 14534739
    [Abstract] [Full Text] [Related]

  • 2. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R, Utting M, Werner W, Schimmel B, Claussen U, Junker K.
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. p53 gene mutation in recurrent superficial bladder cancer.
    Yoshimura I, Kudoh J, Saito S, Tazaki H, Shimizu N.
    J Urol; 1995 May; 153(5):1711-5. PubMed ID: 7715016
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD, Carr MD, Eble JN, Wang M, Lopez-Beltran A, Cheng L.
    Cancer; 2005 Nov 01; 104(9):1901-10. PubMed ID: 16196038
    [Abstract] [Full Text] [Related]

  • 7. Role of chromosome 9 in human bladder cancer.
    Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA.
    Cancer Res; 1993 Sep 01; 53(17):4066-70. PubMed ID: 8358736
    [Abstract] [Full Text] [Related]

  • 8. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S, Mohren K, Knuechel R, Wild PJ, Burger M, Wieland WF, Hartmann A, Stoehr R.
    Hum Pathol; 2006 Feb 01; 37(2):143-51. PubMed ID: 16426913
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns.
    Miyake H, Hara I, Kamidono S, Eto H.
    J Urol; 2004 Sep 01; 172(3):1127-9. PubMed ID: 15311055
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancer.
    Trkova M, Babjuk M, Duskova J, Benesova-Minarikova L, Soukup V, Mares J, Minarik M, Sedlacek Z.
    Cancer Lett; 2006 Oct 08; 242(1):68-76. PubMed ID: 16343743
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. p53 mutations in urinary bladder cancer.
    Berggren P, Steineck G, Adolfsson J, Hansson J, Jansson O, Larsson P, Sandstedt B, Wijkström H, Hemminki K.
    Br J Cancer; 2001 Jun 01; 84(11):1505-11. PubMed ID: 11384101
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.